The Ministry of Health of the Russian Federation has authorized the distribution of the drug that was created by US scientists, but it was not authorized in the USA.
The Russian authorities have approved of the anti-cancer drug that did not obtain US certification.
According to US company spokesman Dr. Garo Armen, the drug has undergone the necessary procedures in the Ministry of Health of the Russian Federation and it may enter the Russia market in late-2008.
“Several days ago we received a license from the Ministry of Health of the Russian Federation to distribute Oncophage among patients on a commercial basis,” said Armen. According to the doctor, “After patients take the drug, the risks for metastasis of cancer after an operation lower by half with them.”
If the information about the vaccine certification is confirmed, it will be the first time that Russia has approved of a drug that was not authorized in the country that had invented it.
In recent years, genetics has become a cutting-edge science, not only in the professional field of biology, but also because of the enormous social reach of its discoveries and approaches. Not in vain, practically every day the press offers us the discovery of a new gene, a new hereditary determinant directly involved in the manifestation of diseases or physical characteristics.
On December 14, President Putin holds his annual Q&A session with Russian and foreign journalists. This conference is considered to be the beginning of his presidential campaign